Books
Public Health Perspective on Intellectual Property and Access to Medicines
A compilation of studies prepared for WHO
South Centre, Geneva, 2016
Author: Carlos M. Correa
A compilation of studies prepared for WHO
South Centre, Geneva, 2016
Author: Carlos M. Correa
The WHO “Red Book” on Access to Medicines and Intellectual Property – 20 Years Later
South Centre, Geneva, 2015
Authors: Germán Velásquez & Pascale Boulet
South Centre, Geneva, 2015
Authors: Germán Velásquez & Pascale Boulet
Some Critical Issues Related to Access to Medicines and Intellectual Property
South Centre, Geneva, 2014
Author: Germán Velásquez
South Centre, Geneva, 2014
Author: Germán Velásquez
Policy Briefs
The Use of TRIPS Flexibilities for the Access to Hepatitis C Treatment
Policy Brief 54, October 2018
Germán Velásquez
Policy Brief 54, October 2018
Germán Velásquez
The International Debate on Generic Medicines of Biological Origin
Policy Brief 50, August 2018
Germán Velásquez
Policy Brief 50, August 2018
Germán Velásquez
The Need to Avoid “TRIPS-Plus” Patent Clauses in Trade Agreements
Policy Brief 37, March 2017
Martin Khor
Policy Brief 37, March 2017
Martin Khor
Research Papers
Acceso a medicamentos: experiencias con licencias obligatorias y uso gubernamental – el caso de la Hepatitis C
Documento de Investigación 85, Mayo 2018
Germán Velásquez
Documento de Investigación 85, Mayo 2018
Germán Velásquez
The International Debate on Generic Medicines of Biological Origin
Research Paper 82, November 2017
Germán Velásquez
Research Paper 82, November 2017
Germán Velásquez
Intellectual Property in the Trans-Pacific Partnership: Increasing the Barriers for the Access to Affordable Medicines
Research Paper 62R, July 2017
Carlos M. Correa
Research Paper 62R, July 2017
Carlos M. Correa